IL13 and type 2 diabetes mellitus: A recent study showed a decrease in serum concentrations of Th2 cytokines, such as IL-4, IL-13, and IL-5, in patients with CAD compared to healthy controls, with no significant differences between those with or without comorbid T2DM [37].